tirzepatide japan Eli Lilly's obesity drug crunch shows signs of easing in Chinese companies turn to generics
Description
Looking beyond SELECT, which focused on secondary prevention, the ultimate prize is still to be seized primary prevention, a huge potential opportunity
Mark Hyman partners with Levels to solve the metabolic health crisis
In fact, the similar pathological mechanisms shared by PD and T2DM have inspired several studies on the therapeutic potential of T2DM drugs against PD, among which glucagon-like peptide-1 receptor (GLP-1R) agonists are promising candidates
We detected a concentration- and time-dependent positive inotropic effect of dulaglutide in HAP
